Drugs News and Research

RSS

Machine learning program could distinguish between two lung cancer types

A new computer program can analyze images of patients' lung tumors, specify cancer types, and even identify altered genes driving abnormal cell growth, a new study shows.

17 Sep 2018

People battling substance use disorders may benefit from meth-relapse prevention compound

New research raises the possibility that a wider group of people battling substance use disorders may benefit from a Scripps Research-developed relapse-prevention compound than previously thought.

17 Sep 2018

Probiotic supplementation may reduce use of antibiotics, scientific analysis shows

Global demand exists for new ways to reduce antibiotic use, given the urgent public health threat of antibiotic resistance.

17 Sep 2018

Ensysce receives award from NIDA to undertake development of opioid overdose protection platform

Ensysce Biosciences Inc. today announced receipt of Notice of Award from the National Institute on Drug Abuse, a four year award to undertake the pre-clinical and clinical development of the company's opioid overdose protection platform MPAR

17 Sep 2018

Researchers map 3D structure of toxic proteins used by Pseudomonas aeruginosa to trigger infection

The bacteria Pseudomonas aeruginosa can cause serious and difficult to treat infections. The infection process involves the activation of toxic substances from the bacteria by a common protein in our cells.

17 Sep 2018

Scientists explore whether seafood could be the source of next anti-cancer drug

Biomedical scientists at the University of Salford found that sugars from the common cockle were approximately as effective as some standard chemotherapy drugs at relative lower dosage.

17 Sep 2018

New Medicare Advantage tool to lower drug prices puts crimp in patients’ choices

Starting next year, Medicare Advantage plans will be able to add restrictions on expensive, injectable drugs administered by doctors to treat cancer, rheumatoid arthritis, macular degeneration and other serious diseases.

17 Sep 2018

Inhaled steroid use linked to greater risk of NTM lung infections

Patients using inhaled steroids to control asthma and other breathing problems may be at greater risk for developing nontuberculous mycobacteria lung infections, according to new research published online in the Annals of the American Thoracic Society.

17 Sep 2018

BPA-free plastic not safe either finds study

We look for labels stating plastics are “BPA-free” to reassure ourselves that the product is safe to eat or drink out of. A new study has shown that BPA-free options are not safe either.

16 Sep 2018

Study shows cost-effectiveness of financial incentive program to control cholesterol

A program that offered financial incentives to both patients and their physicians to control low-density lipoproteins cholesterol could be a cost-effective intervention for patients at high risk of cardiovascular disease, according to new research led by Harvard T.H. Chan School of Public Health.

14 Sep 2018

Half as many people are trying heroin, but marijuana use grows

Some good news from the front lines of the heroin crisis: Half as many people tried heroin for the first time in 2017 as in 2016. That's according to data released Friday from the government's annual National Survey on Drug Use and Health.

14 Sep 2018

Religious upbringing may be protective factor for health, well-being in early adulthood

Participating in spiritual practices during childhood and adolescence may be a protective factor for a range of health and well-being outcomes in early adulthood, according to a new study from Harvard T.H. Chan School of Public Health.

14 Sep 2018

New device to treat acute coronary artery perforations approved by FDA

The U.S. Food and Drug Administration today approved a device intended to treat acute coronary artery perforations, or tears in the blood vessels of the heart. The PK Papyrus Covered Coronary Stent System is the first device approved by the FDA for this indication in 17 years.

14 Sep 2018

Researchers find new way to differentiate between active and inactive viruses

Human herpesviruses such as HHV-6 can remain dormant in cells for many years without being noticed. When reactivated, they can cause serious clinical conditions. Researchers from Würzburg have now found a way of differentiating between active and inactive viruses.

14 Sep 2018

Previously unknown virus acts as 'driver' for interstitial nephropathy

An international research team led by Wolfgang Weninger, who has been Head of MedUni Vienna's Department of Dermatology since 1 September, has discovered a previously unknown virus that acts as a "driver" for certain kidney diseases (interstitial nephropathy).

14 Sep 2018

New technology rapidly assesses antibiotics by using bacteria in bear saliva

If you're looking into the mouth of a brown bear, one of the world's top predators, your chances of survival probably aren't good. But a team of Rutgers and other scientists has discovered a technology that rapidly assesses potentially lifesaving antibiotics by using bacteria in saliva from an East Siberian brown bear.

14 Sep 2018

Study could pave way for new therapies to reverse aging in human cells

Research has shed new light on genetic processes that may one day lead to the development of therapies that can slow, or even reverse, how our cells age.

14 Sep 2018

New project aims to increase patient willingness to take life-saving oral drugs

A new collaboration grant to scientists from Discovery BioMed, Inc. and the Monell Center will support development of next-generation screening technologies to enable identification of bitter taste blockers.

14 Sep 2018

New statement provides detailed overview of how to diagnose, treat resistant hypertension

Resistant hypertension affects 12 percent to15 percent of patients treated for high blood pressure according to a new scientific statement from the American Heart Association.

14 Sep 2018

New clinical trial initiated on experimental vaccine to stop the spread of glioblastoma

Rush University Medical Center is part of a new clinical trial testing whether an experimental vaccine can help patients' immune systems stop the spread of glioblastoma -- an aggressive form of brain cancer with veryhttps://www.rush.edu/news/press-releases/rush-testing-new-brain-cancer-vaccine few current treatment options.

14 Sep 2018

Drugs News and Research

Machine learning program could distinguish between two lung cancer types

People battling substance use disorders may benefit from meth-relapse prevention compound

Probiotic supplementation may reduce use of antibiotics, scientific analysis shows

Ensysce receives award from NIDA to undertake development of opioid overdose protection platform

Researchers map 3D structure of toxic proteins used by Pseudomonas aeruginosa to trigger infection

Scientists explore whether seafood could be the source of next anti-cancer drug

New Medicare Advantage tool to lower drug prices puts crimp in patients’ choices

Inhaled steroid use linked to greater risk of NTM lung infections

BPA-free plastic not safe either finds study

Study shows cost-effectiveness of financial incentive program to control cholesterol

Half as many people are trying heroin, but marijuana use grows

Religious upbringing may be protective factor for health, well-being in early adulthood

New device to treat acute coronary artery perforations approved by FDA

Researchers find new way to differentiate between active and inactive viruses

Previously unknown virus acts as 'driver' for interstitial nephropathy

New technology rapidly assesses antibiotics by using bacteria in bear saliva

Study could pave way for new therapies to reverse aging in human cells

New project aims to increase patient willingness to take life-saving oral drugs

New statement provides detailed overview of how to diagnose, treat resistant hypertension

New clinical trial initiated on experimental vaccine to stop the spread of glioblastoma

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News